منابع مشابه
The Next Step Forward Is to Take a Step Back.
Understanding the causes of diabetes is at the heart of most diabetes research. The field of causal inference has made dramatic advances in methodology that allows for causal inference from observational and not experimental data (1). One such methodological advancement is the use of genetic markers as instrumental variables, or so-called Mendelian randomization (MR) (2). MR relies on the laws ...
متن کاملMoving forward with randomized controlled trials.
A randomized controlled trial (RCT) is the most powerful tool for determining the cause-effect relationship between an intervention and an outcome. RCTs typically include random allocation to intervention and control groups, a blinding plan for trialists, assessors and/or participants, identical treatment groups except for the experimental ingredients, and an intent-to-treat analysis. RCTs are ...
متن کاملComparing active treatments at phase II: using multiple criteria to find the optimal treatment to take forward to phase III
In a Phase II RCT with multiple active treatments, we may often wish to take forward a treatment to Phase III based on multiple criteria and outcomes. In addition to efficacy, factors such as cost and the adverse event rate may play a key role in the decision making process. Using a Bayesian analysis, all relevant criteria can be considered, and a utility function employed to obtain the optimal...
متن کاملCommunity Treatment Programs Take Up Buprenorphine
Clinicians have been working out ways to incorporate buprenorphine into their treatment models. Representatives of three addiction treatment programs - a Veterans Affairs methadone clinic, a group of outpatient mental health centers, and a nationwide organization of therapeutic communities - talk about their plans and experiences.
متن کاملTreatment optimization in MS: Canadian MS Working Group updated recommendations.
The Canadian Multiple Sclerosis Working Group (CMSWG) developed practical recommendations in 2004 to assist clinicians in optimizing the use of disease-modifying therapies (DMT) in patients with relapsing multiple sclerosis. The CMSWG convened to review how disease activity is assessed, propose a more current approach for assessing suboptimal response, and to suggest a scheme for switching or e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Neurology
سال: 2019
ISSN: 1759-4758,1759-4766
DOI: 10.1038/s41582-019-0271-4